content_image/81195.jpg
<img src='content_image/81195.jpg'>

(a) See page 36 for a reconciliation of total segment operating profi t to income from continuing operations before income tax and minority interest, which is the U.S. GAAP fi nancial measure most directly comparable to total segment operating profi t. 

(b) Includes 7,778,425 common shares issuable on conversion of Bunge’s 3.75% convertible notes due 2022. EPS for 2003 and 2002 were revised from the amount previously reported to refl ect the 7,778,425 common shares issuable on conversion of the convertible notes. See notes 1 and 24 to the Notes to Consolidated Financial Statements. 

(c) 2003 excludes an after tax gain on the sale of the Brazilian soy ingredients business of $111 million, or $1.02 per fully diluted share. 

(d) The calculation of return on shareholders’ equity excludes losses in 2003 of $7 million from discontinued operations and gains of $3 million in 2002 and 2001, respectively, from discontinued operations and 2003 also excludes the $111 million gain on the sale of the Brazilian soy ingredients business. 

